Nontyphoidal Salmonella: Gastrointestinal infection and carriage

Authors

  • Rachaneeporn Chueansuwan Division of Internal medicine, Faculty of medicine, Burapha University, Chonburi, Thailand

Keywords:

Nontyphoidal Salmonella, foodborne pathogens, foodborne disease

Abstract

Food-producing animals are the major reservoirs for many foodborne pathogens including non-Typhi serotypes of Salmonella enterica, Nontyphoidal Salmonellae are foodborne gram-negative bacteria that primarily cause gastroenteritis, bacteremia, and focal infection. These bacteria are especially problematic in immunocompromised individuals, including patients with malignancy, human immunodeficiency virus, or diabetes, and those receiving corticosteroid or immunotherapy treatments. Patients with salmonellosis can develop endovascular infection and deep bone or visceral that may be difficult to treat. Therefore, when evaluating treatment choices, it is important to consider the site of infection and the individual’s immune status. The current report presents a brief overview of the problems and trends associated with salmonellosis that are of interest to the infectious diseases clinician.

References

Lynch MF, Tauxe RV, Hedberg CW. (2009). The growing burden of foodborne outbreaks due to contaminated fresh produce: risks and opportunities. Epidemiol Infect, 137(3):307-15.

Centers for Disease Control and Prevention (CDC) GWB, and Jeffrey B. Nemhauser. (2020). CDC Health Information for International Travel 2020 (Yellow Book) : Oxford University Press.

Heredia N, Garcia S. (2018). Animals as sources of food-borne pathogens: A review. Anim Nutr,4(3):250-5.

Chlebicz A, Slizewska K. (2018). Campylobacteriosis, Salmonellosis, Yersiniosis, and Listeriosis as Zoonotic Foodborne Diseases: A Review. Int J Environ Res Public Health, 15(5):863.

Danielle M. Tack, Logan Ray, Patricia M. Griffin, Paul R. Cieslak, John Dunn, Tamara Rissman, et al. (2020). Preliminary Incidence and Trends of Infections with Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2016-2019. MMWR Morb Mortal Wkly Rep, 69(17):509-14.

Taddese D, Tolosa T, Deresa B, Lakow M, Olani A, Shumi E. (2019). Antibiograms and risk factors of Salmonella isolates from laying hens and eggs in Jimma Town, South Western Ethiopia. BMC Res Notes, 12(1):472.

กระทรวงสาธารณสุข. (2562). แผนงานวิจัยด้านการป้องกัน ควบคุมโรคและภัยสุขภาพ พ.ศ. 2562 - 2564. นนทบุรี : กองนวัตกรรมและวิจัย กรมควบคุมโรค กระทรวงสาธารณสุข.

Rubin RH WL. (1977). Salmonellosis: Microbiologic, Pathologic, and Clinical Features. New York : Stratton Intercontinental Medical Book Corp.

Collier-Hyams LS, Zeng H, Sun J, Tomlinson AD, Qin Bao ZQ, Chen H, et al. (2002). Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway. J Immunol, 169(6):2846-50.

Cheverton AM, Gollan B, Przydacz M, Wong CT, Mylona A, Hare SA, et al. (2016). A Salmonella Toxin Promotes Persister Formation through Acetylation of tRNA. Mol Cell, 63(1):86-96.

Fierer J, Krause M, Tauxe R, Guiney D. (1992). Salmonella typhimurium bacteremia: association with the virulence plasmid. J Infect Dis, 166(3):639-42.

Saphra I, Winter JW. (1957). Clinical manifestations of salmonellosis in man; an evaluation of 7779 human infections identified at the New York Salmonella Center. N Engl J Med, 256(24):1128-34.

Octavia S, Wang Q, Tanaka MM, Sintchenko V, Lan R. (2015). Genomic Variability of Serial Human Isolates of Salmonella enterica Serovar Typhimurium Associated with Prolonged Carriage. J Clin Microbiol, 53(11):3507-14.

Hsu RB, Tsay YG, Chen RJ, Chu SH. (2003). Risk factors for primary bacteremia and endovascular infection in patients without acquired immunodeficiency syndrome who have nontyphoid salmonellosis. Clin Infect Dis, 36(7):829-34.

Shimoni Z, Pitlik S, Leibovici L, Samra Z, Konigsberger H, Drucker M, et al. (1999). Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome. Clin Infect Dis, 28(4):822-7.

Musher DM, Rubenstein AD. (1973). Permanent carriers of nontyphosa salmonellae. Arch Intern Med, 132(6):869-72.

Gordon MA, Banda HT, Gondwe M, Gordon SB, Boeree MJ, Walsh AL, et al. (2002). Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS, 16(12):1633-41.

Hung CC, Hung MN, Hsueh PR, Chang SY, Chen MY, Hsieh SM, et al. (2007). Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance. Clin Infect Dis. 2007;45(5):e60-7.

World Health Organization. (‎2005)‎. The treatment of diarrhoea : a manual for physicians and other senior health workers. 4th rev. World Health Organization.

Onwuezobe IA, Oshun PO, Odigwe CC. (2012). Antimicrobials for treating symptomatic non-typhoidal Salmonella infection. Cochrane Database Syst Rev, 2012(11):CD001167.

Blaser MJ, Feldman RA. (1981). From the centers for disease control. Salmonella bacteremia: reports to the Centers for Disease Control, 1968-1979. J Infect Dis, 143(5):743-6.

Leibovitz E, Janco J, Piglansky L, Press J, Yagupsky P, Reinhart H, et al. (2000). Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children. Pediatr Infect Dis J, 19(11):1060-7.

Stevenson JE, Gay K, Barrett TJ, Medalla F, Chiller TM, Angulo FJ. (2007). Increase in nalidixic acid resistance among non-Typhi Salmonella enterica isolates in the United States from 1996 to 2003. Antimicrob Agents Chemother, 51(1):195-7.

Centers for Disease Control and Prevention. (2019). Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: Centers for Disease Control and Prevention; Available at: https://www.cdc.gov/drugresistance/pdf/threatsreport/2019-ar-threats-report-508.pdf. [Accessed April 6, 2020].

Lao WF, Huang CH, Lin CH, Lu MJ, Hung CR. (2012). Endovascular stent graft repair for a Salmonella-infected aneurysm of thoracic aorta. Ann Vasc Surg, 26(5):731.e5-8

Sirinavin S, Thavornnunth J, Sakchainanont B, Bangtrakulnonth A, Chongthawonsatid S, Junumporn S. (2003). Norfloxacin and azithromycin for treatment of nontyphoidal salmonella carriers. Clin Infect Dis, 37(5):685-91.

Citernesi A, Spinelli G, Piazzesi G, Innocenti S, Curiel P. (1994). Screening for Salmonella in pregnancy. Minerva Ginecol, 46(12):681-6.

Rai B, Utekar T, Ray R. (2014). Preterm delivery and neonatal meningitis due to transplacental acquisition of non-typhoidal Salmonella serovar montevideo. BMJ Case Rep, 2014:bcr2014205082.

Sirinavin S, Chiemchanya S, Vorachit M. (2001). Systemic nontyphoidal Salmonella infection in normal infants in Thailand. Pediatr Infect Dis J, 20(6):581-7.

Centers for Disease Control and Prevention (CDC). GWB, and Jeffrey B. Nemhauser. Salmonella Homepage. Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne, and Environmental Diseases (DFWED). https://www.cdc.gov/salmonella/general/prevention.html. Updated February 8, 2019. Accessed.

Published

2021-07-19 — Updated on 2021-08-13

Versions

Issue

Section

Special Article